UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Information needs and research priorities in long‐term survivorship of breast cancer: Patients and health professionals' perspectives

European journal of cancer care, 2022-11, Vol.31 (6), p.e13730-n/a

2022

Volltextzugriff (PDF)

Cross-cultural adaptation, reliability and validity of the Spanish version of the long-term quality of life questionnaire

Frontiers in oncology, 2024-03, Vol.14, p.1375125-1375125

2024

Volltextzugriff (PDF)

2022-RA-1689-ESGO Should immunotherapy be included as first-line adjuvant treatment in high-risk vulvar melanomas?

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A451-A452

2022

Volltextzugriff (PDF)

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1584-1593

2016

Volltextzugriff (PDF)

Hypoglycemic Coma Secondary to Big Insulin‐like Growth Factor II Secretion by a Giant Phyllodes Tumor of the Breast

The breast journal, 2007-03, Vol.13 (2), p.189-191

2007

Volltextzugriff (PDF)

Abstract PS4-12: Potential value of FOXA1 expression as genomic predictor of response to docetaxel and carboplatin neoadjuvant (NA) chemotherapy in patients with triple negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS4-12-PS4-12

2021

Volltextzugriff (PDF)

A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial—A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS5610-TPS5610

2018

Volltextzugriff (PDF)

Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02)

The oncologist (Dayton, Ohio), 2019-11, Vol.24 (11), p.e1115-e1122

2019

Volltextzugriff (PDF)

Abstract PS16-07: Tumor infiltrating lymphocyte stratification refines AJCC TNM staging based outcomes of early-stage triple negative breast cancer treated with neoadjuvant anthracycline-free, docetaxel and carboplatin chemotherapy

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PS16-07-PS16-07

2024

Volltextzugriff (PDF)

Soft tissue sarcomas: A challenge for oncology

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e21512-e21512

2014

Volltextzugriff (PDF)

Tailored treatment with targeted therapies in non-small cell lung cancer (NSCLC) based on the epidermal growth factor receptor gene ( EGFR ) mutation testing

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19150-e19150

2014

Volltextzugriff (PDF)

GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

Future science OA, 2019-02, Vol.5 (2), p.FSO370-FSO370

2019

Volltextzugriff (PDF)

Predictive serum biomarkers in metastatic colorectal cancer (mCRC) patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (BVZ) (GEMCAD 09-01)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14647-e14647

2015

Volltextzugriff (PDF)

Some unusual paraneoplastic syndromes. Case 1. Metastatic squamous cell esophageal cancer to the thumb

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2620-2620

2003

Volltextzugriff (PDF)

Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5549-5549

2021

Volltextzugriff (PDF)

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6027-6027

2014

Volltextzugriff (PDF)

Lumbar region intra-spinal primitive neuroectodermal tumour (PNET) combined with neurofibromatosis type 1

Clinical & translational oncology, 2005-11, Vol.7 (10), p.464-467

2005

Volltextzugriff (PDF)

False Elevation of Serum CA 15-3 Levels in Patients Under Follow-Up for Breast Cancer

The breast journal, 2004-07, Vol.10 (4), p.375-376

2004

Volltextzugriff (PDF)

Factores predictivos de supervivencia a largo plazo del cáncer colorrectal tras la ablación de metástasis hepáticas con control ultrasonográfico

Medicina clínica, 2017-04, Vol.148 (8), p.345-350

2017

Volltextzugriff (PDF)

Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors

Oncology research and treatment, 2018-01, Vol.41 (12), p.755-761

2018

Volltextzugriff (PDF)

Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma

Clinical lymphoma, myeloma and leukemia, 2015-12, Vol.15 (12), p.761-765

2015

Volltextzugriff (PDF)

Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small-cell lung cancer

Cancer chemotherapy and pharmacology, 2005-02, Vol.55 (2), p.152-158

2005

Volltextzugriff (PDF)

Correlation of hypertension and proteinuria with outcomes in elderly bevacizumab (BEV)-treated patients with metastatic colorectal cancer (mCRC): Analysis of the BECOX and BECA studies

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3589-3589

2013

Volltextzugriff (PDF)

Intensive Therapy for Aggressive Lymphoma/DR. MILPIED REPLIES

The New England journal of medicine, 2004-07, Vol.351 (1), p.98

2004

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(60)
Berichte
(3)

Sprache

Englisch
(62)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(19)
Oncology
(14)
Middle Aged
(12)
Female
(10)
Male
(8)
Aged
(6)
Adult
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Breast Cancer
(5)
Heart Failure
(4)
Heart Transplantation
(4)
Biological And Medical Sciences
(3)
Breast Neoplasms - Pathology
(3)
Cardiac & Cardiovascular Systems
(3)
Cardiovascular System & Cardiology
(3)
Chemotherapy
(3)
Inflammation
(3)
Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

9 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Information needs and research priorities in long‐term survivorship of breast cancer: Patients and health professionals' perspectives

Cross-cultural adaptation, reliability and validity of the Spanish version of the long-term quality of life questionnaire

2022-RA-1689-ESGO Should immunotherapy be included as first-line adjuvant treatment in high-risk vulvar melanomas?

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy

Hypoglycemic Coma Secondary to Big Insulin‐like Growth Factor II Secretion by a Giant Phyllodes Tumor of the Breast

Abstract PS4-12: Potential value of FOXA1 expression as genomic predictor of response to docetaxel and carboplatin neoadjuvant (NA) chemotherapy in patients with triple negative breast cancer (TNBC)

Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02)

Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study

Abstract PS16-07: Tumor infiltrating lymphocyte stratification refines AJCC TNM staging based outcomes of early-stage triple negative breast cancer treated with neoadjuvant anthracycline-free, docetaxel and carboplatin chemotherapy

Soft tissue sarcomas: A challenge for oncology

Tailored treatment with targeted therapies in non-small cell lung cancer (NSCLC) based on the epidermal growth factor receptor gene ( EGFR ) mutation testing

GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

Predictive serum biomarkers in metastatic colorectal cancer (mCRC) patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (BVZ) (GEMCAD 09-01)

Some unusual paraneoplastic syndromes. Case 1. Metastatic squamous cell esophageal cancer to the thumb

Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601)

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

Lumbar region intra-spinal primitive neuroectodermal tumour (PNET) combined with neurofibromatosis type 1

False Elevation of Serum CA 15-3 Levels in Patients Under Follow-Up for Breast Cancer

Factores predictivos de supervivencia a largo plazo del cáncer colorrectal tras la ablación de metástasis hepáticas con control ultrasonográfico

Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors

Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma

Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small-cell lung cancer

Correlation of hypertension and proteinuria with outcomes in elderly bevacizumab (BEV)-treated patients with metastatic colorectal cancer (mCRC): Analysis of the BECOX and BECA studies

Intensive Therapy for Aggressive Lymphoma/DR. MILPIED REPLIES

Aktive Filter

Suchergebnisse filtern